Decreased Nonrelapse Mortality after Unrelated Cord Blood Transplantation for Acute Myeloid Leukemia Using Reduced-Intensity Conditioning: A Prospective Phase II Multicenter Trial

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 3, 2015, Pages 445-453

  Rio, Bernard ^a   Chevret, Sylvie ^b   Vigouroux, Stéphane ^c   Chevallier, Patrice ^d   Fürst, Sabine ^e   Sirvent, Anne ^f   Bay, Jacques Olivier ^g   Socié, Gérard ^b   Ceballos, Patrice ^h   Huynh, Anne ⁱ   Cornillon, JérÔme ^j   Françoise, Sylvie ^k   Legrand, Faezeh ^l   Yakoub Agha, Ibrahim ^m   Michel, Gérard ⁿ   Maillard, Natacha ^o   Margueritte, Geneviève ^p   Maury, Sébastien ^q   Uzunov, Madalina ^r   Bulabois, Claude Eric ^s   Michallet, Mauricette ^t   Clement, Laurence ^u   Dauriac, Charles ^v   Bilger, Karin ^w   Gluckman, Eliane ^b   Ruggeri, Annalisa ^b,x   Buzyn, Agnès ^y   Nguyen, Stéphanie ^r   Simon, Tabassome ^a   Milpied, Nöel ^c   Rocha, Vanderson ^b,z   more..

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e INSTITUT PAOLI CALMETTES   (France)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^g UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^h LAPEYRONIE HOSPITAL   (France)

ⁱ TOULOUSE UNIVERSITY HOSPITAL   (France)

^j Institut de Cancérologie de la Loire   (France)

^k ANGERS UNIVERSITY HOSPITAL   (France)

^l UNIVERSITY HOSPITAL OF BESANÇON   (France)

^m LILLE UNIVERSITY HOSPITAL   (France)

ⁿ TIMONE HOSPITAL   (France)

^o POITIERS UNIVERSITY HOSPITAL   (France)

^p MONTPELLIER UNIVERSITY HOSPITAL   (France)

^q HENRI MONDOR HOSPITAL   (France)

^r PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^s GRENOBLE UNIVERSITY HOSPITAL   (France)

^t EDOUARD HERRIOT HOSPITAL   (France)

^u UNIVERSITY HOSPITAL OF NANCY   (France)

^v RENNES UNIVERSITY HOSPITAL   (France)

^w UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^x HÔPITAL SAINT ANTOINE   (France)

^y HÔPITAL NECKER ENFANTS MALADES   (France)

^z CHURCHILL HOSPITAL   (United Kingdom)

more..

Author keywords

Acute myeloid leukemia; Nonrelapse mortality; Reduced intensity conditioning; Umbilical cord blood transplantation

Indexed keywords

ACICLOVIR; AMOXICILLIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUDARABINE; JOSAMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN V; PYRIMETHAMINE PLUS SULFADOXINE; VALACICLOVIR; MYELOABLATIVE AGENT; VIDARABINE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD GROUP ABO INCOMPATIBILITY; CANCER SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEUTROPHIL; PHASE 2 CLINICAL TRIAL; PNEUMOCYSTIS PNEUMONIA; PROSPECTIVE STUDY; REDUCED INTENSITY CONDITIONING; TOXOPLASMOSIS; WHOLE BODY RADIATION; ADOLESCENT; AGED; ALLOGRAFT; ANALOGS AND DERIVATIVES; CHILD; CLINICAL TRIAL; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; RISK FACTOR; SURVIVAL RATE; UNRELATED DONORS;

ADOLESCENT; ADULT; AGED; ALLOGRAFTS; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; UNRELATED DONORS; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 84922876497     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.11.009     Document Type: Article

References (32)

1. Bacigalupo A., Ballen K., Rizzo D., et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009, 15:1628-1633.
2. Appelbaum F.R. Dose intensity of preparative regimens for acute myeloid leukemia - one-size-fits-all or tailor-made?. Best Pract Res Clin Haematol 2010, 23:509-517.
3. Martino R., de Wreede L., Fiocco M., et al. Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT. Bone Marrow Transplant 2013, 48:761-770.
4. Aoudjhane M., Labopin M., Gorin N.C., et al. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia 2005, 19:2304-2312.
5. Sorror M.L., Sandmaier B.M., Storer B.E., et al. Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. JClin Oncol 2007, 25:4246-4254.
6. Oran B., Wagner J.E., DeFor T.E., et al. Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. Biol Blood Marrow Transplant 2011, 17:1327-1334.
7. Eapen M., Rocha V., Sanz G., et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010, 11:653-660.
8. Rocha V., Labopin M., Ruggeri A., et al. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies. Transplantation 2013, 95:1284-1291.
9. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. NEngl J Med 2004, 351:2265-2275.
10. Brunstein C.G., Gutman J.A., Weisdorf D.J., et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010, 116:4693-4699.
11. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110:3064-3070.
12. Frassoni F., Gualandi F., Podesta M., et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008, 9:831-839.
13. Delaney C., Heimfeld S., Brashem-Stein C., et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010, 16:232-236.
14. de Lima M., McNiece I., Robinson S.N., et al. Cord-blood engraftment with exvivo mesenchymal-cell coculture. NEngl J Med 2012, 367:2305-2315.
15. Rocha V., Broxmeyer H.E. New approaches for improving engraftment after cord blood transplantation. Biol Blood Marrow Transplant 2010, 16:S126-S132.
16. Barker J.N., Weisdorf D.J., Wagner J.E. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. NEngl J Med 2001, 344:1870-1871.
17. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343-1347.
18. Brunstein C.G., Eapen M., Ahn K.W., et al. Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood 2012, 119:5591-5598.
19. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
20. Terwey T.H., Vega-Ruiz A., Hemmati P.G., et al. NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia. Leukemia 2012, 26:536-542.
21. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. JAm Stat Assoc 1958, 53:457-481.
22. Cox D.R. Regression models and life tables. JR Stat Soc 1972, 34:187.
23. Rocha V., Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol 2009, 147:262-274.
24. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915-1919.
25. Rocha V., Mohty M., Gluckman E., Rio B. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol 2009, 21(Suppl 1):S31-S34.
26. Brunstein C.G., Fuchs E.J., Carter S.L., et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011, 118:282-288.
27. Eiz-Vesper B., Seltsam A., Blasczyk R. ABO glycosyltransferases as potentialsource of minor histocompatibility antigens in allogeneic peripheral blood progenitor cell transplantation. Transfusion 2005, 45:960-968.
28. Klumpp T.R. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991, 8:159-170.
29. Berglund S., Le Blanc K., Remberger M., et al. Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation. Transplantation 2012, 94:1066-1074.
30. Romee R., Weisdorf D.J., Brunstein C., et al. Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation. Bone Marrow Transplant 2013, 48:1046-1049.
31. Konuma T., Kato S., Ooi J., et al. Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning. Biol Blood Marrow Transplant 2014, 20:577-581.
32. Ponce D.M., Sauter C., Devlin S., et al. Anovel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation. Biol Blood Marrow Transplant 2013, 19:799-803.